YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...
Elevated interest rates continue to hurt InMode’s revenue, especially as lease package interest rates haven't fallen yet. Still, future rate cuts could release pent-up demand. InMode continues to buy ...
YOKNEAM, Israel, April 14, 2025 /PRNewswire/ --InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial ...
InMode's Q1 2025 results disappointed, with revenue and EPS missing estimates, leading to a 12% stock drop and another potential guidance cut. Despite solid fundamentals and attractive valuation, ...
A lot of (digital) ink tends to get spilled about how much businesses grow their revenues each quarter. But sometimes, like with InMode's (NASDAQ: INMD) second-quarter earnings, the most exciting ...
In 2021, it seemed as if medical technology stocks could do no wrong. Shares of cosmetic sculpting device manufacturer InMode (NASDAQ: INMD) more than doubled as enthusiasm for all things new and ...
IRVINE, Calif. - InMode Ltd. (NASDAQ:INMD), a prominent provider of medical technology, has obtained a favorable ruling from the US District Court for the Central District of California in its fight ...
InMode's customers need to buy consumable products to use with their devices. The more consumables the company sells, the more recurring revenue it gets. Sales of its consumables are rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback